Axiogenesis iPSC - iPSC (ID:70001)
| HMS LINCS ID: | 70001 |
| Name: | Axiogenesis iPSC |
| Alternative Names: | iPSCs derived from human dermal fibroblasts by Ncardia, previously Axiogenesis |
| LINCS ID: | |
| Alternative ID: | |
| Parent Primary Cell: | |
| Citation Information for Mutations: | |
| Molecular Features: | |
| Passaging Method: | |
| Passage Last Karyotyping: | |
| Recommended Culture Conditions: |
Complete culture medium recipe: 450mL IMDM (PAN,P04-20150) 500μL Insulin (Insulin solution human, I9278, Sigma) 50mL Fetal calf serum (heat inactivated) Thioglycerol (400 μM)BMCC serum free culture medium recipe: 500ml IMDM (PAN,P04-20150) 500μl Insulin (Insulin solution human, I9278, Sigma) 5ml CD-Lipids (CD Lipids concentrate, 11905-031, Gibco) 500μl Trace Elements A ( 25-021-CI, Cellgro) 500μl Trace Elements B ( 99-175-CI, Cellgro) 500μl Trace Elements C (99-176-CI, Cellgro) 250μl Vitamin C ( 100mg/ml Stock) Thioglycerol (400 μM) |
| Molecular Features: | |
| Related Projects: | |
| Cell Markers: | |
| Genetic Modification(s): | |
| Production Details: | generated using the Yamanaka protocol (inducing factors Oct3/4, Sox2, Klf4, c-Myc) |
| Comments: | |
| Date Publicly Available: | 2017-09-29 |
| Most Recent Update: | 2018-03-20 |
Batch Information:
| HMS LINCS Batch ID | Provider | Provider Catalog ID | Provider Batch ID |
|---|---|---|---|
| 70001-1 | Ncardia, previously Axiogenesis |